WHO Discovers Ebola Drugs Found to Increase ‘Survival Rates by 90%’

Ebola Patient

There’s been a breakthrough on Ebola, according to World Health Organization officials. The breakthrough in the cure for the deadly virus was achieved following results from a clinical trial of two therapies made from Ebola antibodies.

According to Naija News, in Democratic Republic of Congo where there is a major outbreak of the virus, four Ebola drugs was administered to patients and two showed that 90% of infected people can survive if treated early.

The therapies that have improved survival rates are REGN-EB3, a cocktail of three monoclonal Ebola antibodies made by Regeneron Pharmaceuticals (REGN), and mAb114, a single monoclonal antibody developed by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Patients who were receiving two other drugs that are being discontinued, Zmapp and remdesivir, will now have the option at the discretion of their treating physician to receive the treatments that have been shown to work.

Read also: Masquerade Begs for Mercy As He is Mercilessly Flogged by a Soldier

REGN-EB3 and mAb114 are the first drugs that, in a scientifically sound study, have clearly shown a significant diminution in mortality for people with Ebola virus disease,” Anthony Fauci, director of the NIH’s National Institute of Allergy and Infectious Diseases, told AFP.

It means that we do have now what looks like treatments for a disease which not too long ago we really had no therapeutic approach at all,” said Dr. Anthony Fauci, director of NIAID.

“We feel that with agents such as these … that we may be able to improve the survival of people with Ebola and … might even make people more enthusiastic about coming for care.

“Because when you have something to offer an individual, it makes it much more likely that you might get to them early. And the earlier the better, as in any disease” he added.

Leave a Reply